Supply Chain

RFID and battery-powered containers are among the developments receiving attention in the pharmaceutical cold chain.

FDA relies on e-chips to thwart bogus products, and drops paper pedigrees and unit-of-use packaging.

FDA and manufacturers seek to curb drug counterfeiting while legislators consider liberalizing drug importing policies to cut pharmaceutical costs.

Brand and product security technologies offer pharmaceutical manufacturers anticounterfeiting solutions.

Near-infrared spectroscopy is a sophisticated and selective technique that has emerged as a powerful tool for the analysis of pharmaceuticals.